Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jul 24 11:33AM ET
Dollar change
Percentage change
Index- P/E895.87 EPS (ttm)0.01 Insider Own0.56% Shs Outstand136.53M Perf Week0.65%
Market Cap1.45B Forward P/E5.31 EPS next Y2.04 Insider Trans0.00% Shs Float133.15M Perf Month-34.78%
Income5.00M PEG- EPS next Q0.40 Inst Own80.98% Short Float0.07% Perf Quarter-41.81%
Sales1.12B P/S1.29 EPS this Y12.73% Inst Trans- Short Ratio0.29 Perf Half Y-37.74%
Book/sh0.07 P/B147.30 EPS next Y15.40% ROA0.31% Short Interest0.09M Perf Year-54.73%
Cash/sh2.46 P/C4.40 EPS next 5Y- ROE12.20% 52W Range9.14 - 24.77 Perf YTD-29.01%
Dividend Est.- P/FCF- EPS past 5Y-62.20% ROI1.81% 52W High-56.25% Beta0.75
Dividend TTM- Quick Ratio0.74 Sales past 5Y3.60% Gross Margin81.14% 52W Low18.60% ATR (14)0.70
Dividend Ex-DateJun 16, 2016 Current Ratio0.92 EPS Y/Y TTM111.00% Oper. Margin1.16% RSI (14)31.75 Volatility4.51% 4.15%
Employees1164 Debt/Eq27.90 Sales Y/Y TTM18.57% Profit Margin0.44% Recom1.00 Target Price25.55
Option/ShortYes / Yes LT Debt/Eq26.70 EPS Q/Q8.55% Payout- Rel Volume2.78 Prev Close11.02
Sales Surprise-5.25% EPS Surprise-10.84% Sales Q/Q12.25% EarningsApr 25 BMO Avg Volume320.98K Price10.84
SMA20-16.23% SMA50-30.00% SMA200-38.63% Trades Volume311,998 Change-1.63%
Date Action Analyst Rating Change Price Target Change
Jul-23-24Initiated Piper Sandler Overweight $22
Apr-03-24Initiated Craig Hallum Buy $37
Jul-13-23Initiated Northland Capital Outperform $35
Jul-18-24 10:01AM
Jul-10-24 12:57PM
Jul-09-24 08:25AM
02:39PM Loading…
Jul-03-24 02:39PM
Jun-18-24 03:40PM
Jun-10-24 02:30PM
May-24-24 09:06AM
May-23-24 07:02AM
Apr-26-24 01:01PM
Apr-25-24 07:53AM
03:44AM Loading…
Apr-04-24 09:27AM
Mar-19-24 09:55AM
Mar-11-24 02:43PM
Mar-07-24 11:56AM
Feb-29-24 02:02AM
Feb-23-24 06:54AM
Feb-22-24 06:02AM
Nov-13-23 09:35AM
Nov-09-23 07:15AM
02:05AM Loading…
Oct-23-23 11:35AM
Oct-11-23 04:20PM
Oct-02-23 11:50AM
Sep-26-23 02:30PM
Sep-25-23 11:53AM
Sep-07-23 11:42AM
Aug-29-23 08:50AM
Aug-21-23 02:46PM
Jul-27-23 02:00AM
Jun-14-23 01:53PM
Indivior PLC is a holding company, which engages in the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence. Its products include Suboxone Film, Suboxone Tablet, and Subutex Tablet. It operates through the following geographical segments: United States, Rest of World, and United Kingdom. The company was founded on September 26, 2014 and is headquartered in North Chesterfield, VA.